EMA Authorised: Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) (sevelamer carbonate) — Sanofi Winthrop Industrie

View source ↗

Summary

EMA has authorised Sevelamer carbonate Winthrop for treating hyperphosphatemia in patients on renal dialysis (formerly Zentiva), with Sanofi Winthrop Industrie …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• Sevelamer carbonate Winthrop (sevelamer carbonate)

Snippet

Status: Authorised. Therapeutic area: Hyperphosphatemia;Renal Dialysis. MAH: Sanofi Winthrop Industrie. Decision date: 12/12/2024